Hello PF agree with your thinking re Diasource.
Further proof we are on the right company and that a loan will possibly be part used to merge with them. A report released on 20 Oct 2015 about the Radioimmunoassay market that Diasourrce is a major player in.
http://www.prnewswire.com/news-rele...ket-worth-4284-million-by-2020-534538821.html
Some quotes
"Over the years, there has been a significant growth in the utilization of radioimmunoassay technique in Europe owing to the advancements in medical research, clinical trials, and pharmaceutical industries. Over the next five years, the growth in the Asian Radioimmunoassay Market is expected to be centered in China, India, and Japan. The European Radioimmunoassay Market contributed the largest share in the global market, and was valued at $121.5 million in 2014. It is projected to reach $154.6 million by 2020, at a CAGR of 3.9% during the given forecast period. The limitations of the global RIA market are its high cost; government restrictions; and continuous innovations in the biomedical research for other immunoassay techniques, such as enzyme-linked immunosorbent assay (ELISA) kits. Major companies operational in the Radioimmunoassay Market are DIAsource ImmunoAssays SA (Europe), Immunotec Inc. (Canada), and DIAsource ImmunoAssay S.A.(Europe)."
"the global Radioimmunoassay (RIA) Market was valued at $345.2 Million in 2014 and is expected to reach $428.4 Million by 2020, at a CAGR of 3.5% during the forecast period from 2015 to 2020."
The sweet smell of cashflow and low interest rates = Part loan to be used in the merger. (up to $5M IMO)
ADO Price at posting:
9.7¢ Sentiment: Buy Disclosure: Held
